AMO, Pharma

AMO Pharma Announces Collaboration with Population Health Research Institute to Advance Proof of Concept Clinical Trial to Assess Efficacy of Tideglusib in Treatment of Arrhythmogenic Cardiomyopathy

Published on 08/07/2025 at 18:09 | prnewswire.co.uk

AMO Pharma Limited Population Health Research Institute (PHRI) United Kingdom

View original content:https://www.prnewswire.co.uk/news-releases/amo-pharma-announces-collaboration-with-population-health-research-institute-to-advance-proof-of-concept-clinical-trial-to-assess-efficacy-of-tideglusib-in-treatment-of-arrhythmogenic-cardiomyopathy-302062622.html

en | CA7609751028 | AMO | boerse | 67920674 |